Clinical Trial Update: The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT) [Phase 2]

View source ↗

Summary

The document notes the completion of a Phase 2 trial evaluating apremilast for rheumatoid arthritis (CARAT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Baylor Research Institute | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED